What Investors Look For as Key Indicators of Value and Success in a Life Sciences Company

Life Science investing requires investors to carefully assess and consider a number of key factors in determining the investment merits and future returns of a potential investment. This includes evaluating the clinical benefits of an opportunity and the size and attributes of the likely addressable market, mapping out possible regulatory pathways, determining the optimum reimbursement approach, and understanding the current and future competitive landscape. A solid Intellectual property position is an essential linchpin in determining value and weighing the probable exit multiples. Management capabilities and experience clearly must be considered as well. Forecasting capital requirements, identifying likely strategic acquirers, and understanding appropriate value inflection and decision points all contribute to the “to invest or not” thought processes of investors. 

Presenter included: John L. Brooks III, President and Managing Director, Medical Capital Advisors, LLC